Preliminary data from an ongoing phase IIb study of no carrier added 131I-iobenguane (nca-MIBG) in patients with malignant pheochromocytoma (Pheo). Absence of human papilomavirus (HPV) in tissues ...
Two separate studies report a range of mutations involved in the disease and one discovers an inhibitor. New evidence on the molecular mechanisms that underlie aberrant NF-kB activity in multiple ...
Primary resistances to EGFR inhibitors (EGFRi) in HPV-positive and -negative oropharyngeal squamous cell carcinoma (OSCC). Background: Our previous study on prostate cancer (PCa) tissues shows that ...
Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, No. 24 (Jun. 16, 2009), pp. 9619-9624 (6 pages) Mammalian signaling networks contain an abundance of negative ...
UA researchers participated in the discovery of an unexpected role played by a protein molecule, making it a candidate for a biomarker or drug target for breast cancer. University of Arizona ...
BOSTON -- Muscle wasting is associated with aging and a serious consequence of different diseases, including cancer and diabetes. Researchers at Joslin Diabetes Center, with the assistance of other ...
CHAPEL HILL, N.C. – Cases of human papillomavirus (HPV)-associated cancers of the head and neck, known as head and neck squamous cell carcinoma (HNSCC), are rapidly increasing throughout the United ...